WASHINGTON, D.C. – Scott Whitaker, president and CEO of the Advanced Medical Technology Association (AdvaMed), issued the following statement on Senate passage of the 21st Century Cures Act:
Press Release | December 7, 2016
Statement | November 30, 2016
WASHINGTON, D.C. – Scott Whitaker, president and CEO of the Advanced Medical Technology Association (AdvaMed), issued the following statement after passage in the U.S. House of the 21st Century Cures Act.
Press Release | November 30, 2016
WASHINGTON, D.C. – Scott Whitaker, president and CEO of the Advanced Medical Technology Association (AdvaMed), today issued the following statement regarding the nomination of Rep. Tom Price (R-Ga.) as Secretary of the Department of Health and Human Services (HHS)
December 14, 2016 | Webinar
If you want to drive retention at your company, it’s time to start mentoring. Mentoring has a big ROI for companies, in terms of aligning cultures, keeping millennials, and maximizing the workforce.... Read More
February 21, 2017 to February 22, 2017| Bogotá, Colombia
To view this event in English, please click here. Estamos muy contentos de anunciar la conferencia de 2017 América Latina Cumplimiento, prevista para febrero 23 de, 2017 en el JW Marriott Bogotá. ... Read More
Medical technology aids in the prevention, diagnosis and treatment of various conditions to enhance quality of life and help you enjoy more of life's precious moments.
Little Falls, NJ - Cantel Medical Corp.
LITTLE FALLS, New Jersey (December 8, 2016) ... CANTEL MEDICAL CORP. (NYSE:CMD) reported record US GAAP net income of $18,800,000, or $0.45 per diluted share, on a 22.1% increase in sales to a record $187,725,000 for the first quarter ended October 31, 2016. This compares with net income of $14,254,000, or $0.34 per diluted share, on sales of $153,779,000 for the first quarter ended October 31, 2015. Non-GAAP net income increased 24.6% for the first quarter ended October 31, 2016 to $21,323,...
Syracuse Media Group
Skaneateles, N.Y. — Welch Allyn plans to add 100 new jobs to its medical equipment factory in Skaneateles, already one of Central New York's largest employers.
Cohera Medical, Inc.® Receives FDA Approval to Begin Clinical Trials of its Sylys® Surgical Sealant in the U.S.
Cohera Medical Inc.
RALEIGH, N.C., July 12, 2016 (GLOBE NEWSWIRE) Cohera Medical, Inc., a leading innovator and developer of absorbable surgical adhesives and sealants, today announced that it has received Investigational Device Exemption (IDE) approval from the United States Food and Drug Administration (FDA) to begin a prospective, multicenter, randomized clinical trial for its Sylys® Surgical Sealant device.
Fox News Channel
Heart disease is the number one cause of death for both men and women in the United States. Claiming approximately 1 million lives per year, heart attacks alone strike someone every 43 seconds. On January 20, 2014, that someone was me.
Opioid addiction, abuse, and overdose are at the forefront of our national dialogue. But by casting opioids as the villain, this important conversation is missing an essential element: how best to treat the chronic pain that afflicts 100 million Americans, including many of our wounded warriors. Chronic pain is a multifaceted problem with a range of causes and solutions, not a two-dimensional condition that can only be treated with opioids.
December 9, 2016 - 8:00pm